About Inline Pharmaceuticals Private Limited
Data last updated:
Inline Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24117TG2019PTC137780. Its GSTIN is 36AAFCI5126H1ZN (Telangana).
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Srilakshmi Yarlagadda and Trinath Tummepalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.B – 5 Tie Phase – II Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.44 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹12.44 Lakh (net margin 8.7%) and EBITDA of ₹59.76 Lakh (EBITDA margin 41.6%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years.
The company is associated with 1 brand: Inline Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.91 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website inlinepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.B – 5 Tie Phase – II Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Inline Pharmaceuticals Private Limited
The main business activity of Inline Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Inline Pharmaceuticals Private Limited FY 2025 filings available
Inline Pharmaceuticals Private Limited reported revenue of ₹1.44 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Inline Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 53% over three years, including 36% growth in the latest year. EBITDA rose 132% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Inline Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹59.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.44 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Inline Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Inline Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Industrial Chemicals, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Perfect Pharmaceuticals Consultant Private Limited | ₹1.45 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Pune, Maharashtra, India |
| Wakils Pharmaceuticals Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Absolute Chemicals Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Jinnaram, Telangana, India |
| Anushoam Pharmaceuticals Private Limited | ₹1.44 Cr (FY 2018) | •••• | •••• | •••• | Kanchipuram, Tamil Nadu, India | |
| Atrol Pharmaceuticals Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 935.0% | •••• | Bangalore South, Karnataka, India |
| Inline Pharmaceuticals Private Limited this company | ₹1.44 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Hyderabad, Telangana, India |
| Cogniwell Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2024) | •••• | •••• | -28.0% | •••• | Bangalore, Karnataka, India |
| 2D Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2024) | •••• | •••• | -83.0% | •••• | Uppal, Telangana, India |
| Skinzone Pharmaceuticals India Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Thane, Maharashtra, India |
| Brunhild Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2024) | •••• | •••• | 57.0% | •••• | Naigaon, Maharashtra, India |
| Calcutta Chem Tech Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Parganas North, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Inline Pharmaceuticals by revenue in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals Private Limited is audited by S L R & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S L R & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srilakshmi Yarlagadda Also directs: Transactonne Material Sciences Private Limited | Director | 20 Dec 2019 | 6 Years 9 Months | Current |
| Trinath Tummepalli Also directs: Mahakram Health LLP, Sealink Impex Pharma Private Limited, Oak Vance Life Sciences Private Limited and 2 more | Director | 09 Mar 2022 | 4 Years 6 Months | Current |
Ownership and Shareholding of Inline Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Inline Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2024 | State Bank of India | ₹2 Cr | Open |
| 28 Sep 2024 | Others | ₹90.65 Lakh | Open |
Total charge records: 2 View all charges
Associated Brands with Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals operates one associated brand: Inline Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports pharmaceutical APIs, nutraceuticals, and oral dissolving strips globally. | inlinepharma.com |
Employees and EPFO Compliance at Inline Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Inline Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Ganesh Harry ceased to be Director on 25 Feb 2023.
Credit Ratings, Litigation & Regulatory Alerts for Inline Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Inline Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Inline Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCI5126H1ZN | Telangana | Active | 01 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Inline Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inline Pharmaceuticals Private Limited
Inline Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 December 2019 (7+ years old) and is registered under CIN U24117TG2019PTC137780.
Inline Pharmaceuticals reported revenue of ₹1.44 Cr for FY 2025 (up 36% YoY).
Inline Pharmaceuticals has 2 current directors:
- Srilakshmi Yarlagadda - Director
- Trinath Tummepalli - Director
Inline Pharmaceuticals reported a net profit of ₹12.44 Lakh (net margin 8.7%) and EBITDA of ₹59.76 Lakh (EBITDA margin 41.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Inline Pharmaceuticals is 53% over three years. In the latest year (FY 2025) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Inline Pharmaceuticals is 36AAFCI5126H1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Inline Pharmaceuticals is U24117TG2019PTC137780. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inline Pharmaceuticals was incorporated on 20 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Inline Pharmaceuticals by revenue are Perfect Pharmaceuticals Consultant Private Limited, Wakils Pharmaceuticals Private Limited, Absolute Chemicals Private Limited, Anushoam Pharmaceuticals Private Limited, Atrol Pharmaceuticals Private Limited and 5 more, all in the Chemicals industry (Industrial Chemicals, Pharmaceuticals).
Ganesh Harry ceased to be Director on 25 Feb 2023. Trinath Tummepalli was appointed as Director on 09 Mar 2022. Rama Rao Tummepally ceased to be Director on 12 Feb 2022. Inline Pharmaceuticals has 7 board changes on record in total.
Yes, Inline Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).